Key result
Catechin-folate nano-niosomes induce ~93% cytotoxicity in ovarian cancer cells via apoptosis and cell-cycle arrest.
Why the study?
The study was conducted to establish the mechanism of how catechin fractions of Osbeckia parvifolia Arn. could be used as a therapeutic treatment for ovarian cancer.
Catechin-folate nano-niosomes from Osbeckia parvifolia demonstrate significant in vitro cytotoxicity against ovarian cancer cells through apoptosis and cell-cycle arrest.
May guide nano-niosome optimization for ovarian cancer; leaves open in vivo validation before any clinical consideration.
The current study establishes the mechanism on how dietary flavonoid, catechin fractions of Osbeckia parvifolia Arn. could be used as a therapeutic treatment for ovarian cancer, using a combination of network pharmacology, molecular validation and nano-formulations. From network modelling analysis, 420 protein targets linked to ovarian cancer, including five that act as major regulatory hubs – AKT1, STAT3, IL6, ESR1 and CASP3 were found. Catechin had the strongest binding affinity to all of these five hub proteins, especially for ESR1 (-11.089 kcal/mol) and AKT1 (-9.221 kcal/mol). In molecular dynamics simulation studies over 100 ns, catechin bonded strongly with its target proteins. HPLC guided fractionation (RT: 3.887 min) LC-MS/MS (RT:6.51 min), HPTLC (Rf: 0.973) were performed, which resulted in the confirmation of the presence of both catechin and epicatechin and verified the biosynthetic pathway of both through the measurement of the expression of their respective biosynthetic genes LAR (0.3637 folds) and ANR (0.2746 folds) in O. parvifolia . The evaluation of the six different nano-formulations of phytoniosomes led to F5 being the most stable with uniform spherical architecture, having an optimal particle size (229.2 nm), a high positive zeta potential (+ 42.7mV), and having the highest cytotoxicity (93.17%) in SKOV3 cells, the mechanism of action being through apoptosis induction and cell-cycle arrest. Hence, this study supports the hypothesis that catechin extracted from O. parvifolia can serve as an effective therapeutic candidate for the targeted treatment of ovarian cancer.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2026) studied Ovarian cancer. Catechin-Folate nano-niosomes (F5) vs. Untreated control was evaluated on Cytotoxicity in SKOV3 cells. Catechin-folate nano-niosomes formulated from Osbeckia parvifolia demonstrated high stability and induced 93.17% cytotoxicity in SKOV3 ovarian cancer cells through apoptosis and cell-cycle arrest.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: